Matches in Nanopublications for { ?s ?p "[COX-2 expression correlates with VEGF expression and might be a useful prognostic factor for more frequent tumor recurrence in esophageal squamous carcinoma patients undergoing neoadjuvant chemoradiotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP99544.RAtII0jbdwcRm0FCaCh7aVtgqYwwImQ92ftvBRj0faqcU130_assertion description "[COX-2 expression correlates with VEGF expression and might be a useful prognostic factor for more frequent tumor recurrence in esophageal squamous carcinoma patients undergoing neoadjuvant chemoradiotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP99544.RAtII0jbdwcRm0FCaCh7aVtgqYwwImQ92ftvBRj0faqcU130_provenance.
- NP120230.RAtPlklwN8Rr3-p6ZkEcLD9SWl12Zd0NtwmXJIErIlfy0130_assertion description "[COX-2 expression correlates with VEGF expression and might be a useful prognostic factor for more frequent tumor recurrence in esophageal squamous carcinoma patients undergoing neoadjuvant chemoradiotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP120230.RAtPlklwN8Rr3-p6ZkEcLD9SWl12Zd0NtwmXJIErIlfy0130_provenance.
- NP99690.RAI4KG1QoZ9R__k4MWV87wEgWqzRhuVpfjkP4ksnrIfdA130_assertion description "[COX-2 expression correlates with VEGF expression and might be a useful prognostic factor for more frequent tumor recurrence in esophageal squamous carcinoma patients undergoing neoadjuvant chemoradiotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP99690.RAI4KG1QoZ9R__k4MWV87wEgWqzRhuVpfjkP4ksnrIfdA130_provenance.
- NP120195.RA7nL_uTDKJaB11ORUbSFOjTcBZliJ0r1mPRkYm_MBFMg130_assertion description "[COX-2 expression correlates with VEGF expression and might be a useful prognostic factor for more frequent tumor recurrence in esophageal squamous carcinoma patients undergoing neoadjuvant chemoradiotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP120195.RA7nL_uTDKJaB11ORUbSFOjTcBZliJ0r1mPRkYm_MBFMg130_provenance.
- NP183388.RAwI5EKJwb0LyPFPHutdisIEOtQ8xPZKwO283_VHj6qGg130_assertion description "[COX-2 expression correlates with VEGF expression and might be a useful prognostic factor for more frequent tumor recurrence in esophageal squamous carcinoma patients undergoing neoadjuvant chemoradiotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP183388.RAwI5EKJwb0LyPFPHutdisIEOtQ8xPZKwO283_VHj6qGg130_provenance.
- NP183423.RA9Bucgnh060HZXY-qbepXCnpgB8_BDicM7GLf3kuxAdo130_assertion description "[COX-2 expression correlates with VEGF expression and might be a useful prognostic factor for more frequent tumor recurrence in esophageal squamous carcinoma patients undergoing neoadjuvant chemoradiotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP183423.RA9Bucgnh060HZXY-qbepXCnpgB8_BDicM7GLf3kuxAdo130_provenance.
- NP225381.RA8kwYKG_9pHEjHf_XsWx6_UjS6ejBVepJA_Ah0_PlrXw130_assertion description "[COX-2 expression correlates with VEGF expression and might be a useful prognostic factor for more frequent tumor recurrence in esophageal squamous carcinoma patients undergoing neoadjuvant chemoradiotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP225381.RA8kwYKG_9pHEjHf_XsWx6_UjS6ejBVepJA_Ah0_PlrXw130_provenance.
- NP225380.RAdkF44eimIch1kcte3Qn84TofqeF3rr3A358UcjmQaec130_assertion description "[COX-2 expression correlates with VEGF expression and might be a useful prognostic factor for more frequent tumor recurrence in esophageal squamous carcinoma patients undergoing neoadjuvant chemoradiotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP225380.RAdkF44eimIch1kcte3Qn84TofqeF3rr3A358UcjmQaec130_provenance.
- NP162777.RAEGbxkjZe3rxiM8HSSFJdktv3bh9HSCHDdhKX07CvH_Y130_assertion description "[COX-2 expression correlates with VEGF expression and might be a useful prognostic factor for more frequent tumor recurrence in esophageal squamous carcinoma patients undergoing neoadjuvant chemoradiotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP162777.RAEGbxkjZe3rxiM8HSSFJdktv3bh9HSCHDdhKX07CvH_Y130_provenance.
- NP162922.RALDq9xtI3bbX6uwaFsDSzAQGtHt3wGEy2GNNoU5b2v3o130_assertion description "[COX-2 expression correlates with VEGF expression and might be a useful prognostic factor for more frequent tumor recurrence in esophageal squamous carcinoma patients undergoing neoadjuvant chemoradiotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP162922.RALDq9xtI3bbX6uwaFsDSzAQGtHt3wGEy2GNNoU5b2v3o130_provenance.
- assertion description "[COX-2 expression correlates with VEGF expression and might be a useful prognostic factor for more frequent tumor recurrence in esophageal squamous carcinoma patients undergoing neoadjuvant chemoradiotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[COX-2 expression correlates with VEGF expression and might be a useful prognostic factor for more frequent tumor recurrence in esophageal squamous carcinoma patients undergoing neoadjuvant chemoradiotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.